The levels of CD4+ T helper and Tfh cells were similar in the severe and non-severe COVID-19 patients, as shown in Figure 4 The activated CD4+CXCR5+ICOS+Foxp3-Tfh cells were significantly elevated in severe COVID-19 patients compared to patients with non-severe disease (p < .0001). This evidence concerns the gene ICOS and COVID-19.